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Weakness and fatigability are typical features of Duchenne muscular dystrophy patients and are 
aggravated in dystrophic mdx mice by chronic treadmill exercise. In the present study, we describe, 
the pattern of differentially abundant spots that is associated to the worsening of dystrophy 
phenotype induced by chronic exercise. Our proteomic analysis pointed out 34 protein spots with 
different abundance between sedentary and exercised mdx mice. These proteins belong mostly to 
glucose metabolism, energy production and sarcomere structure categories. Interestingly exercise 
induced an increase of typical fast twitch fiber proteins (Troponin T fast skeletal muscle, Troponin I 
fast skeletal muscle and Myozenin-1) combined with an increase of several glycolytic enzymes. 
Concerning energy transfer, Adenylate kinase, showed a marked decrease when compared with 
non-exercised mdx. The decline of this enzyme correlates with increased Creatin kinase enzyme, 
suggesting that a compensatory energy metabolism mechanism could be activated in mdx mouse 
skeletal muscle following exercise. In addition, we analysed muscles from exercised mdx mice 
treated with two natural anti-oxidant compounds, apocynin and taurine, that in our previous study, 
were proved to be beneficial on some pathology related parameters, and we showed that these 
compounds can counteract exercise-induced changes in the abundance of several proteins.  
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Duchenne Muscular Dystrophy (DMD) is a severe, X-chromosome linked disease inherited muscle 
disorder caused by the absence of functional dystrophin protein. It affects 1 in 5000 boys 
worldwide; no definitive treatment for this disease is available yet. DMD is characterized by muscle 
membrane fragility, progressive myofiber death and replacement of skeletal muscle by fibrous and 
connective tissue (due to failed regeneration). This results in extensive wasting, weakness and loss 
of muscle function leading to premature death. 
The dystrophin-deficient mdx mouse is the most common animal model for DMD [1], and it is 
characterized by a nonsense mutation in exon 23 of the dystrophin gene. The mdx mice phenotype 
of the disorder is milder than in human sufferers. This difference arises from differences in size, 
mechanical loading and lifespan [2]. These mice present an acute onset of pathology around 3-4 
weeks of age, that is reduced to a chronic low level of damage by 8 weeks and persists throughout 
life [3]. Compared to DMD patients, mdx mouse muscles show less accumulation of connective and 
adipose tissue and are characterized by a better recover from the wasting. In fact, although the 
necrotic process persists throughout their life, the regenerative capacity does not decline until an 
advanced age (around one year) [4]. 
Since regular exercise has a plethora of positive effects on health and muscle performance, exercise 
has been proposed as treatment for DMD, but this recommendation has not been unanimously 
accepted because inappropriate exercise damages dystrophic muscles [5,6]. The establishment of 
the exact boundary line between a proper and unsuitable exercise is challenging. The effect of 
exercise in mdx mouse model has been largely used for basically three purposes: i) assessing the 
physical capacities of the mice, ii) investigating the effects of training on dystrophic muscles, iii) 
worsening the phenotype in order to assess the effects of a drug [5]. In the context of worsen the 
mild dystrophic phenotype of mdx mice, various models of exercise-induced muscle damage, 
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including forced wheel or treadmill running, and swimming, were used.  These protocols can mimic 
the muscle progressive damage observed in humans, can allow studying the effects of inadequate 
training on dystrophic muscles and have been largely used to assess the ability of a drug to reduce 
the damage induced by exercise [3,5]. Several proteomic studies, comparing wild type and mdx 
muscles were performed [7–12], however only few investigated the effect of exercise [13,14]. In 
particular, these studies were focused on the beneficial effect of a low intensity exercise, while the 
effect of high intensity protocols has never been investigated by a proteomic approach. In a 
previous study, we analyzed how a chronic protocol of treadmill exercise affects the in vivo 
performance and the expression of specific molecules involved in muscle damage and regeneration 
in mdx mice [15]. We demonstrated that this protocol reduces functional performance in vivo in 
mdx mice. In parallel, we demonstrated that exercised mdx mice showed changes in expression 
genes indicating a failure in mechanical metabolic coupling. In particular, we observed an impaired 
ability of adaptation to exercise of protective metabolic oxidative pathways, while the gene 
expression of proteins involved in damaging signals, such as oxidative stress and inflammation, 
remains upregulated. Importantly, no change was detected in wild-type mice, the protocol being too 
mild to induce training effects in healthy animals [15]. The more severe phenotype induced by 
chronic exercise is useful to test the beneficial effects of drugs and natural compounds, among 
which anti-oxidant and anti-inflammatory drugs [16-18]. In the present study, we describe, for the 
first time, the pattern of differentially abundant spots that is associated to the worsening of 
dystrophy phenotype induced by chronic exercise. Our investigation includes the protein profile in 
tibialis anterior muscle of wild type, mdx mice and mdx mice undergoing a standard 4 weeks’ 
protocol of exercise on treadmill. In particular, we focused our attention to changes induced by 
exercise in the mdx phenotype, showing significant alteration of several metabolic pathways 
including glucose one, as well as sarcomere structure organization. In addition, we also analyzed 
muscle from exercised mdx mice treated with two natural anti-oxidant compounds, apocynin and 
taurine, proved to be beneficial on some pathology related parameters [16], in order to assess, at 
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proteomic level, if the exercise and pathology related changes could be counteracted by these 
compounds.  
 
2. Materials and Methods 
2.1 Animal model and exercise  
The present study was performed using the hind limb muscle samples of experimental mice groups 
previously used [16,19]. In particular, muscle samples used in this study are referred to the 
following mice and experimental groups: male mdx mice (C57BL/10ScSn-Dmdmdx/J from 
Jackson Laboratories) divided in sedentary mdx (mdx) mice or exercised mdx (mdx exe) mice, mdx 
exercised mice treated with taurine (mdx exe tau) or apocynin (mdx exe apo) and C57/BL wild-type 
(wt) mice. The age of all mice at the beginning of the study was 4-5 weeks while muscle sampling 
was performed at 8-10 weeks of age.  The training protocol consisted of a 30 min running on a 
horizontal treadmill (Columbus Instruments, USA) at 12 m/min, twice a week (keeping a constant 
interval of 2–3 days between each trial), for 4 weeks. The doses of taurine and apocynin were 1 
g/kg (orally) and 38 mg/kg (1.5 mmol/l in drinking water) respectively. The treatment started one 
day before the beginning of the exercise protocol, lasted at least 4 weeks and continued until the day 
of sacrifice. A group of age-matched male wild-type mice (C57BL/10) has also been used as 
control. The animals were sacrificed after 48-72 hours after the last exercise session to avoid acute 
effects of exercise to be detected [19]. Muscles were removed, immediately frozen in liquid 
nitrogen and stored at −80 °C until use for biochemical evaluations. The animals used in this 
proteomic study were 5 for each group. 
2.2 Muscle sample preparation and two-dimensional gel electrophoresis 
Muscle protein extracts were prepared as previously described [20]. Briefly, frozen muscles were 
ground in dry ice in a cooled mortar, suspended in lysis buffer (50 mM Tris–HCl pH 7.0, 150 mM, 
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NaCl, 2 mM EGTA, 100 mM NaF, 1% (v/v) NP-40, 0.5% (w/v), deoxycholate, 0.1% (w/v) SDS 
containing a cocktail of protease inhibitors (Sigma) and solubilized by sonication on ice. 
After centrifugation (8000 RCF, for 5 m) proteins were precipitated following a 
chloroform/methanol protocol [21] and suspended in 8 M urea, 4% (w/v) CHAPS, 50 mM DTT. 
Protein samples (60 μg for silver stained gels and 700 μg for preparative gels) were separated on 
18-cm immobilized pH gradient (IPG) strips (pH 3-10 NL) on PROTEAN® i12™ IEF System 
(BIO-RAD). In particular, the strips were actively rehydrated (at 50V), for 14 hours, in the presence 
of sample in rehydration solution (8 M urea, 2% (w/v) CHAPS, 0.5% (w/v) DTE) supplemented 
with 0.5% (v/v) carrier ampholyte (Bio-Rad) and a trace of bromophenol blue. The strips were then 
focused at 16°C according to the following electrical conditions: 250 V for 20 m (rapid), from 250V 
to 8000V for 1 h, 8000V until a total of 43000 V/h was reached, with a limiting current of 50 
μA/strip. Analytical gels were stained with ammoniacal silver nitrate as previously described [22]; 
MS-preparative gels were stained with colloidal Coomassie blu silver [23]. 
2.3 Image analysis and statistics 
In this study we used 5 animals for group (biological replicates) and for each animal two 2DE gels 
were carried out (technical replicates), so that, in total 50 gels were analyzed. Silver-stained gels 
were scanned using the Epson expression 1680 PRO scanner. The gel images were saved with a 
resolution of 300 dpi and in 16-bit TIFF format. Image analysis was carried out using the 
Progenesis SameSpots software v4.0 (Nonlinear Dynamics, UK), which allows spot detection, 
background subtraction and protein spot volume quantification. The gel image showing the highest 
number of spots and the best protein pattern was chosen as the reference image and its spots were 
then matched across all gels. This reference image was used to quantify and normalize the spot 
volumes. The spot volumes were normalized in each gel as relative volume (volume percentage), by 
dividing the raw quantity of each spot by the total quantity of all the spots included in the reference 
gel. Statistical analysis was performed using default parameters of the Progenesis SameSpots Stat 
module. The log10-normalized spot volume was used for the analysis as the log transformation 
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improves normality [24]. The univariate data analysis was performed as one-way ANOVA on each 
spot individually. Then, a multivariate statistic was applied on all the ANOVA p-values by the 
False Discovery Rate (FDR) correction method. Moreover, we performed a power analysis to assess 
the number of sample replicates that need to be analyzed in order to confidently discover 
differentially abundant proteins. The accepted power threshold is ≥ 0.8.62 The differences were 
considered significant for the spots having a corrected p-value (FDR) ≤0.05 and a power ≥0.8. 
These spots were subjected to mass spectrometry analysis. Tukey correction for multiple 
comparison was performed with GraphPad Prism v6.0 software in order to find out the significant 
differences between groups.  
2.4 Mass spectrometry (MS) protein identification 
Electrophoretic spots were manually excised, destained, and acetonitrile dehydrated. A trypsin 
solution (0.25 mg/ml) in 50 mM ammonium bicarbonate was added for in-gel protein digestion by 
overnight incubation at 37 °C. Solutions containing digested peptides were recovered and 20 µL of 
1% TFA 50% ACN were added to each spot and sonicated for 10 minutes to maximize peptide 
recovery. At the end, for each spot, all recovered peptide solutions were combined and 
concentrated. From each protein digest, 0.75 µL were spotted onto the MALDI target and allowed 
to air dry at room temperature. Then, 0.75 µL of matrix solution (saturated solution of a-cyano-4-
hydroxy- cinnamic acid in 50% (v/v) acetonitrile and 0.5% (v/v) TFA) was applied to the sample 
and crystallized by air drying at room temperature for 5 min. Protein identification was carried out 
by peptide mass fingerprinting (PMF) on an Ultraflex III MALDI- TOF/TOF mass spectrometer 
(Bruker Daltonics) equipped with a 200 Hz smartbeamt I laser. MS analysis was performed in the 
positive reflector mode according to defined parameters, as follows: 80 ns of delay; ion source 1: 25 
kV; ion source 2: 21.75 kV; lens voltage: 9.50 kV; reflector voltage: 26.30 kV; and reflector 2 
voltage: 14.00 kV. The applied laser wavelength and frequency were 353 nm and 100 Hz, 
respectively, and the percentage was set to 46%. Final mass spectra were produced by averaging 
1500 laser shots targeting five different positions within the spot. Spectra were acquired 
8 
 
automatically and the Flex Analysis software version 3.0 (Bruker) was used for their analysis and 
for the assignment of the peaks. The applied software generated a list of peaks up to 200, using a 
signal-to-noise ratio of 3 as the threshold for peak acceptance. Recorded spectra were calibrated 
using, as the internal standard, peptides arising from trypsin auto-proteolysis. The mass lists were 
filtered for contaminant removal: mass matrix- related ions, trypsin auto-lysis and keratin peaks. 
Protein identification by Peptide Mass Fingerprint search was established using MASCOT search 
engine version 2.1 (Matrix Science, London, UK, http://www.matrixscience.com) through the 
UniProtKB database (accession December 2016) (http://www.uniprot.org/). Taxonomy was limited 
to Mus musculus, a mass tolerance of 100 ppm was allowed, and the number of accepted missed 
cleavage sites was set to one. Alkylation of cysteine by carbamidomethylation was considered a 
fixed modification, while oxidation of methionine was considered as a possible modification. The 
criteria used to accept identifications included the extent of sequence coverage, the number of 
matched peptides, and a probabilistic score of p ≤ 0.05. 
2.5 Bioinformatic functional analysis 
Identified proteins were used as input list in order to obtain a categorization and an over-
representation analysis (ORA) using the Webgestalt online tool (“WEB-based GEne SeT AnaLysis 
Toolkit”) (http://www.webgestalt.org/) against GeneOntology (GO) and WikiPathway [25]. The 
statistics performed in the over-representation analysis (ORA) dealt with the p-value obtained from 
the Fisher exact test followed by the p-value adjusted for multiple testing by the Benjamini-
Hochberg correction.  
2.6 Western blot analysis 
For 1DE, protein extracts were separated by 12% SDSPAGE and transferred onto a PVDF 
membrane (Millipore). The relative abundance of Aldolase, Enolase, Triosephosphate isomerase, 
Actin, PGC-1α, Sirt1, proteins was assessed by Western blot with appropriate antibodies (Aldolase, 
Enolase, Triosephosphate isomerase Actin, PGC-1α antibodies from Santa Cruz Biotechnology; 
Sirt1 antibodies from Cell Signalling). Oxphos complexes were analysed, by immunoblot, using 
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Total OXPHOS Rodent WB Antibody Cocktail (Abcam). For quantification, the blots were 
subjected to densitometric analysis performed using ImageJ image processing program [26]. For the 
normalization, PVDF membranes were stained with Coomassie brilliant blue R-250 and the 
intensity of the each immunostained band was normalized on protein staining of the corresponding 
whole lane. Statistical analysis of the data was performed by Student's t-test using GraphPad Prism 
software; p-values ≤0.05 were considered statistically significant.  
 
3.  Results and Discussion 
3.1 Overview of overall proteomic analysis 
In order to better understand how exercise impacted protein abundance in mdx mice, proteins from 
tibialis anterior (TA) of sedentary mdx (mdx) and mdx mice after four weeks of exercise (mdx exe) 
were separated by 2DE and protein profile were analyzed using Progenesis SameSpot software v4.0 
(Nonlinear Dynamics, UK). We also included in this analysis TA muscle proteins extracted from 
wild type mice (wt), that was considered as referring phenotype, and mdx exercised animals treated 
with taurine (mdx exe tau) and apocynin (mdx exe apo) as previously described [16]. The 2DE gel 
images were analysed by the software using default parameters. After automatic spot detection, an 
average of about 970 protein spots was detected in each gel (Figure 1). The computational 2DE gel 
image analysis pointed out 120 spots showing different abundance (ANOVA p-value ≤ 0.05). In 
addition to univariate analysis (ANOVA-test), multivariate analyses (q-value, PCA and power 
analysis) were performed to explore categories of differential protein level. To reduce the expected 
level of false positive, we performed a statistical analysis on the ANOVA p-values, by applying the 
false discovery rate correction method known as q-value. A statistically significant q-value (≤0.05) 
was found for 112 protein spots. Moreover, we calculated the power of our statistical analysis: in 
our experiments, we achieved a target power of 87% confirming that the number of sample 
replicates used was appropriate. The abundance of the spots was considered statistically different 
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when associated with a q-value ≤ 0.05 and a power ≥0.8. To obtain an overview of the proteomic 
data for overall trends in all groups, PCA was performed. Gels were grouped according to the 
variance of protein spot abundance. In PCA biplot, each point describes the collective expression 
profiles of one sample and plot demonstrates consistent reproducibility between the replicate 
samples within each group. The PCA biplot, shown in Figure 2, reveals two distinct main protein 
profile groups corresponding to: i) mdx and wt (red circle), ii) mdx exe and mdx exe treated with 
apocynin and taurine (blu circle). Interestingly, two populations are clearly present inside each 
group: in i) mdx (pink dots) and wt (light blue dots) are almost completely separated indicating that 
the differences in protein abundance characterize these two different phenotypes; in ii) mdx exe 
(blue dots) tends to cluster differently from mdx exe treated with compounds (violet and yellow 
dots) that show the same trend of variation. PCA plot suggests that exercise drastically affect 
protein pattern and that this effect can be partially modified by taurine and apocynin. In order to 
identify these spots, preparative 2DE gels were performed and colloidal Coomassie stained. Protein 
spots are highlighted with circles and numbers in the representative gel shown in Figure 1. These 
spots were subjected to mass spectrometry analysis and 97 proteins were successfully identified. 
The results of mass spectrometry identification are reported in Table 1, together with the 
corresponding spot numbers, ANOVA p-value, adjusted p-value (FDR) and MS data (score and 
coverage values). The experimental isoelectric point (pI) and molecular mass (Mr) values of the 
identified proteins mostly matched with those theoretically predicted from the genome sequence 
although some fragments were present. More than one protein spot was found to correspond to the 
same protein, consistently with the presence of different post-translationally modified forms of the 
protein. Trypsin digests of some spots with low Mascot (PMF) score value or with discrepancy 
between theoretical and calculated MW or pI were further analysed performing peptide sequencing 
by tandem mass spectrometry. MS/MS analysis was carried out by using an Ultraflex III MALDI- 
TOF/TOF mass spectrometer (Bruker Daltonics) and the results were reported Table 1 in ref. [27]. 
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PCA analysis pointed out a significant impact of exercise on protein profile of mdx mice: in fact, 
exercised mdx mice clustered separately from both mdx and wt mice that tend to be closer in PCA 
biplot. Hence, we dedicated a brief paragraph to the analysis of mdx vs wt variations. In fact, 
differences between wild-type and mdx muscles, at proteomic level, have been widely documented 
[9-12,28,29], but not in tibialis anterior muscle. Then, we mainly focused our analysis on mdx exe 
vs mdx. The results concerning the effect of taurine and apocynin are reported in a separate 
paragraph and they were discussed in the light of the main outcomes arising from the comparison 
between mdx and mdx exe. In Figure 1 and 2 in ref. [27], histograms and picture representing spot 
abundance variation between each condition are reported. 
3.2 Differential abundances of spots in non-exercised mdx tibialis anterior muscle in comparison to 
wild type 
 In our proteomic experimental design, we included wild type mice in order to have a referring 
phenotype. Differences in protein profile between wild-type and mdx hind limb muscles have been 
widely documented [10,12,28]. However, to our knowledge, the only proteomic study on tibialis 
anterior muscle, investigated the age-related change in protein abundance in the mdx genotype, 
while a comparison with wild type has been not described [7]. Hence, in Table 2, the 23 protein 
spots (corresponding to 15 different proteins) showing a significant difference between mdx and wt 
animals are reported. The identified proteins mostly belong to sarcomere structure, glucose 
metabolism and energy transfer. Mdx mice show a down regulation of glycolytic enzymes, Ckm 
enzyme and a general decrease of sarcomeric proteins. Tibialis anterior muscle is composed mostly 
by fast glycolytic fibers with high expression of glycolytic enzymes and Ckm in order to support 
anaerobic metabolism [30]. The general decrease of these enzymes is in agreement with the 
increased basal expression of slow-genes observed in our study at transcriptional level [15,19] while 
the decrease in Ckm can be related to the typical loss of the enzyme due to membrane leakiness. 
Comparable results on protein level, were obtained by D. Gardan-Salmon in gastrocnemius muscle 
from six weeks old mice [12]. Differently the proteomic analysis performed on three months old 
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mice (muscles: soleus, extensor digitorum longus, flexor digitorum brevis and interosseous) by 
Carberry et al. indicated a general increase of both proteins categories with the exceptions of 
Fructose-bisphosphate aldolase in flexor digitorum brevis and Ckm in soleus [10]. Overall, these 
data confirm that, muscle types and different ages of mdx mice, must be carefully considered before 
drawing a general conclusion on the impact of dystrophin lack on muscle protein level.  
3.3 Exercise induced protein abundance variation in mdx mice 
In mdx mice, exercise induces variation of 64 spots corresponding to 34 different proteins. These 
spots are indicated in Table 3 together with fold change and Tukey post –ANOVA p-value. To 
better understand the biological meaning behind the list of identified proteins, we performed a gene 
ontology (GO) overrepresentation analysis, using the web accessible tool WebGestalt, as specified 
in Materials and Methods. The enriched GO terms, together with enriched pathways are reported in 
Figure 3. The most representative information came to light from the enrichment analysis, 
investigated combining proteomic results with immunoblot approach, are described separately as 
follows.  
Muscle contraction and sarcomere organization 
Considering proteins involved in muscle contraction and in sarcomere organization, exercise 
induces an increase of fast Troponin T (Tnnt3), Troponin I (Tnnt2), Myozenin-1 (Myoz1), Actin 
and LIM domain-binding protein 3 (Ldb3), whereas Myosin regulatory light chain 2 (Mylpf), 
Myosin light chain 1/3 (Myl1) and Tropomyosin alpha-1 chain (Tpm1) were downregulated (Figure 
4). Interestingly, Tnnt2, Tnnt3 and Myozenin1 are typical fast twitch proteins, and Myoz1 KO 
induced a fast to slow transition and a decrease in fatigue [31,32]. Then their upregulation is again a 
sensor of defective adaptation to exercise (in line with gene-expression data) and may in part 
account for increased fatigability. Mylpf and Myl1 are the two low molecular weight proteins non-
covalently attached to myosin molecule. Myosin is a hexameric ATPase cellular motor protein. It is 
composed of two heavy chains, two non-phosphorylatable alkali light chains, and two 
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phosphorylatable regulatory light chains. Myl1 is the myosin alkali (or essential) light chain 
expressed in fast skeletal muscle while Mylpf represents the regulatory and phosphorylatable 
component. Phosphorylation of Mylpf light chains protein plays a pivotal role in muscle and 
modulates mechanical aspects of muscle function, resulting in potentiation of isometric and 
concentric force and in enhancing dynamic aspects of muscle work and power in unfatigued or 
fatigued muscle [33]. Furthermore, also the abundance of this protein is important since it was 
demonstrated that extraction of the myosin regulatory light chain 2, disorders myosin head 
structure, moving them away from the backbone of the thick filament [34]. Its decreasing level, 
together with the decreasing abundance of Tropomyosin can contribute to explain the reduction of 
in vivo performance showed by the exercised mice [15]. On the other hand, other important 
component of sarcomere structure, belonging to thin filaments (Actin, Tnnt3 and Tnnt2) and Z-disk 
(Ldb3 and Myoz1), resulted up-regulated. Hence, exercise seems to modulate differently the level 
of the sarcomeres’ proteins which may in part account for compensatory mechanisms on function 
[19].  It is also noteworthy that the three spots corresponding to Lim binding domain protein, that 
may function as an adapter to couple protein kinase C-mediated signalling via its LIM domains to 
the cytoskeleton, were increased, but they corresponded to a fragment of the protein. In fact, 
checking the apparent molecular weight and the peptide coverage, we observed that these spots 
have an apparent molecular weight lower than the one expected and furthermore, the peptide 
coverage is limited to the N-terminus of the protein, suggesting an activation of proteolysis (Table 2 
in ref. [27]). It is also interesting to note an increased level of two spots, corresponding to Tnnt3, 
which showed a shift in pI value, indicating that exercise increased the level of a Tnn3 isoform 
harbouring post-translational modification. The variation of actin abundance was confirmed by 
immunoblot analysis shown in Figure 5A.  
In Table 3 in ref [27] we also reported the differentially abundant proteins between mdx exe and wt. 
It is worth noting that in mdx exercised mice, the number of proteins that show a different level in 
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comparison to wt is greater than in the comparison mdx vs wt (34 and 22 respectively). In 
particular, concerning sarcomere protein abundance, we found that exercise induce a further 
decrease of proteins directly involved in contraction (Tpm1, Tpm2, Actin and Mylpf ) whereas 
proteins belonging to Z-disk (Ldb3, Myot) resulted increased.  
Glycolysis and gluconeogenesis pathways 
Glucose metabolism results greatly modified in mdx mice after exercise. In fact, we found several 
spots corresponding to three enzymes of glycolysis, Fructose-bisphosphate aldolase A, 
Triosephosphate isomerase, Beta-enolase (Aldoa, Tpi1, Eno3), with an increased level after 
exercise. We also include in this group the enzyme UTP-glucose-1-phosphate uridylyltransferase 
(Ugp2) that has a central role as a glucosyl donor in glycogen synthesis and in the production of 
glycolipids, glycoproteins, and proteoglycans. This enzyme resulted also up regulated after 
exercise. In order to validate the proteomic results, we performed an immunoblot of AldoA, EnoB 
and Tpi1 enzymes (Figure 5 B).  
TCA cycle and respiratory chain complex 
After exercise, two enzymes of TCA cycle resulted increased: Fumarate hydratase (Fh) and Malate 
dehydrogenase (Mdh2). These two enzymes are involved in the two final steps of oxaloacetate 
regeneration that can be used for both TCA cycle and amino acids production. We included in this 
group also the enzyme Delta-1-pyrroline-5-carboxylate dehydrogenase (Aldh4a1) that catalyses the 
irreversible conversion of delta-1-pyrroline-5-carboxylate derived from either proline or ornithine, 
to glutamate and plays an important role in suppling intermediate substrates of TCA; also, this 
enzyme is up-regulated after exercise.  Concerning electron transport chain and ATP production, we 
found a decreased abundance of NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 
(Ndufb7), a protein that belongs to Complex I and an increased level of a fragment of ATP synthase 
subunit alpha (Atp5a1) that belongs to the catalytic core of ATP synthase. To better analyse the 
abundance of electron chain complexes and to bring out differences in the amount of low abundant 
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proteins that could not be easily detected in a total protein extract by 2DE, we performed an 
immunoblot using Total OXPHOS Rodent WB Antibody Cocktail. This cocktail contains 5 mouse 
mAbs, against one subunit of each complex (Figure 6). By immunoblot we confirmed the decreased 
concentration of complex I and we uncovered an increased level of complex II and a decreased 
level of complex III, whereas complex IV and complex V resulted unchanged. As shown in Figure 
7, exercise induces a general increase of enzymes involved in glucose metabolism and in TCA 
cycle, whereas, concerning electron transport chain and ATP production, complex I and III showed 
a reduced abundance while complex II had the opposite behaviour. This could be explained 
considering that complex II is strictly connected to TCA cycle. In fact, the succinate dehydrogenase 
belongs to complex II, thus the oxidation of succinate to fumarate is the sole Krebs reaction that 
takes place on the inner membrane itself, as opposed to the other reactions that are catalysed by 
soluble enzymes [35]. The energy carrier flavin adenine dinucleotide (FAD) is also a part of the 
succinate dehydrogenase complex. Hence, the increased level of this complex is in agreement with 
the increased level of TCA enzymes. It is also important to underline that also in severely 
compromised mitochondria, succinate dehydrogenase activity, can usually be spared, as long as 
fragments of the inner membrane remain [36]. In this context, we can speculate that in exercised 
mdx mice, there is an increased level of anaerobic metabolism (increased glycolysis), while 
mitochondria function could be partially compromised. In this scenario, the role of TCA cycle could 
be the anaplerotic one: it means that the cycle could be mostly used to produce precursors of other 
metabolic compounds. In fact, we found an up-regulation of Aldh4a1, involved in the synthesis of 
glutamate from alpha-ketoglutarate and up-regulation of Fh, and Mdh2 involved regeneration of 
oxaloacetate that can be used for amino acid synthesis.  
Energy transfer 
Creatine kinase (Ckm) and Adenylate kinase (Ak1) are essential enzymes in tissues characterized 
by high and sudden increases of energy demand. After exercise, we observed an increased level of 
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several spots of Ckm whereas Ak1 shows a marked decrease when compared with mdx. Ak1 
catalysed the reversible reaction ATP+AMP to 2ADP and it represents the key enzymes in the 
synthesis and equilibration of adenine nucleoside [37]. A reduction of Ak1 expression in mdx mice 
in comparison to wild-type, was detected by Ge Y. et al in mdx hindlimb muscles. [11] These 
authors also demonstrated that the decline of active Ak1 activity correlated with increased Ckm 
activity, suggesting that a compensatory energy metabolism mechanism might exist in mdx mouse 
skeletal muscle. Furthermore, it was observed that, in Ak1 knockout mice, there is a deep alteration 
of energetic homeostasis. In fact, in these mice, the nucleotide levels are maintained, but the 
glycolytic flux and Ckm-P turnover are increased [38]. Our results clearly indicate that exercise 
induce a decrease of Ak1 protein level and an increased level of glycolytic enzymes (Eno3, Aldoa, 
Tpis1). These findings suggest that in exercised mdx mice, as showed for Ak1 knockout mice, there 
is a compensatory increase of glycolytic pathway. According to this observation, in mdx exe, we 
also found an increased level of several spots of Ckm. Concerning this enzyme, it must be 
highlighted that several spots (55, 56, 57, 58, 59, 60) presented an experimental molecular weight 
lower than the one expected (Table 1) indicating that the increased level of this protein (observed 
for spots 61, 62,64, 65, 67 and 69), is also combined with and increased proteolysis. The protein 
peptide coverage of these spots, Table 2 of ref [27], indicates that they correspond to amino-
terminal fragment of the protein. 
3.4 Exercise related proteins 
PGC1-alpha and its upstream regulator Sirt1 are key proteins involved in muscle response to 
exercise [39]. In particular, PGC1-alpha is an important regulator of mitochondrial bio-genesis and 
oxidative metabolism and it is involved in fast to slow transition of muscle fibres. Sirt1 is induced 
by NAD
+
 and regulates metabolism by repressing glycolytic genes [40,41]. In a previous study we 
demonstrated that PGC1-alpha and its upstream regulator Sirt1 genes were up-regulated in mdx 
versus age-matched wt muscles in basal condition and accordingly, an overexpression of signalling 
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genes related to slow-phenotype genes was evident [15]. Furthermore, we demonstrated that, 
PGC1-alpha and Sirt1 genes expression remained stable after 4 weeks of exercise and decrease after 
a more prolonged exercise protocol (16 weeks). This trend is opposite of the one observed in wild 
type mice subjected to exercise [42] and clearly indicates a maladaptation to exercise of mdx mice. 
In order to confirm these data also at protein level, we performed an immunoblot of PGC1-alpha 
and Sirt1. We include in this blot also the wild-type mice, since the increased protein level of these 
two proteins in non-exercised mdx is important to better understand the mdx muscle response to 
exercise. As shown in Figure 8, immunoblot confirmed the data obtained with our previous gene 
expression analysis, indicating that both proteins are more expressed abundant in mdx mice in 
comparison to control mice. After exercise, the protein level of PGC1-alpha and Sirt1 were 
unchanged, unless a tendency to decrease was detected for Sirt1. 
3.5 Apocynin and taurine modulation of proteomic changes induced by exercise 
In a previous study we showed the ability of apocynin and taurine in counteracting some of the 
deleterious effects induced by the exercise [16]. Here, the effects of these compounds were analysed 
at a proteomic level. As shown in the PCA biplot (Figure 2), exercise was the main source of 
variation between the groups analysed in this study, but the treatment with taurine and apocynin 
represented a partially separated clusters of protein abundance modification. We divided these 
protein spots in three groups presented in Table 4. The first group is formed by proteins whose level 
is modified by exercise, but that, with taurine and/or apocynin treatment, show a reduction of this 
modification that became non-significant. The second group includes spots that show a significant 
variation between mdx exe and mdx exe treated with compounds. Most of the proteins of these two 
groups, belonged to glucose metabolism and energy transfer pathways, both resulted increased after 
exercise. The data related to these two groups, mean that these treatments were able to counteract 
the effect that exercise induced on the abundance of these proteins and that in some cases, (group II) 
this effect is significantly reverted. It is interesting to note that proteins involved in sarcomere 
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organization or muscle contraction were little represented in this two groups (spot 2 corresponding 
to Ldb3, spot 18 corresponding to Tpm1 and spot 22 corresponding to Actin). Lastly, the third 
group is composed by spots that behave in intermediate way between the two previous groups. In 
this group, we found two spots corresponding to Troponin T and Troponin I whose increase 
abundance induced by exercise, is reduced by apocynin treatment. See also Figure 1 in ref.  [27] for 
a detailed report of spot variations. All the spots not present in these three groups showed the same 
behaviour after exercise. (i.e. they were significantly modified with or without treatments). In 
Figure 9 a clustering representation the three groups is reported. 
4. Conclusions 
The exercised mdx mice present a more severe phenotype than sedentary mdx, in fact they show an 
increased weakness and fatigability, along with muscle necrosis and fibrosis, elevated oxidative 
stress and worsened calcium homeostasis [43,44]. However, the molecular mechanisms responsible 
for the intolerance to exercise are not fully understood. In a previous work, based on gene 
expression profiling of key proteins involved in exercise response, we showed that dystrophic 
muscles have a defect in mechano-transduction signalling and that this defect is mostly ascribable to 
Sirt1, PGC1-alpha related pathways. In fact, we showed that Sirt1 and PGC1-alpha RNAs are 
higher in mdx animal than in wt and that exercise induces a significant and marked reduction in 
PGC1-alpha expression, particularly evident after 16 weeks of exercise [15]. In this study, we 
analysed, for the first time, the impact of a chronic exercise protocol, on protein abundance in 
tibialis anterior muscle of mdx mice. Our data, together with previously data performed on RNA 
level, indicate that mdx mice show a higher basal level of PGC1-alpha and Sirt1 proteins in 
comparison to wt. In agreement with gene expression data in GC muscle, four weeks of exercise are 
not able to induce variation in protein abundance of these two proteins but clearly failed to stimulate 
the metabolic changes associated to fast-to-slow transition typically observed in aerobically trained 
muscle [45,46]. In fact, mdx exercised mice display an increased level of several enzymes of 
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glycolysis, Krebs cycle and related anaplerotic pathways whereas complex I and Complex III of the 
electron transport chain are decreased. It also worth noting the strong down regulation of Ak1 
enzyme in mdx exercised mice. In healthy muscles expression of adenylate kinase isoforms 
increases in response to exercise [47]. In fact, the catalytic function of adenylate kinase is 
particularly important in tissues with high and fluctuating energy demands since it allows the 
utilization of the second high-energy bond of the β-phosphoryl in the ATP molecule, thereby 
doubling the energetic potential that the cell can use. Furthermore, by sensing the energy status of 
muscle cells and regulating gene expression, the Ak1 and downstream AMP signalling are critical 
regulators of mitochondrial biogenesis, through the AMPK-PGC-alpha signalling cascade [48]. 
Importantly, we recently showed that a long exercise protocol led to a significant increase of 
pAMPK/AMPK in wt muscles, while it failed to adapt the higher pAMPK/AMPK ratio observed in 
sedentary mdx muscles [19]. Hence, why Ak1 is downregulated by exercise, and how this 
downregulation is related to a compensatory rearrangement of energy production and eventually to 
an alteration of AMP mediated signalling, are important points that need to be more investigated.  
However, at the moment, this represents an important mechanism for altered mechanical-metabolic 
coupling in dystrophic muscle. Concerning proteins involved in muscle structure and contraction, it 
is interesting to note that sedentary mdx mice show a downregulation of Mylpf, Tpm2 and Tpm1 
and that this trend is worsened by exercise and this is particularly evident for Mylpf. On the other 
hand, in exercised mdx some proteins of Z-disk and of thin filaments are upregulated in comparison 
to non-exercised mdx, although some of them correspond to a fragment of the protein.  Taken 
together these results confirm the global alteration of the abundance of sarcomeres’ proteins and 
suggest that exercise could exacerbate this feature both decreasing the expression of myosin 
regulatory light chain 2 and/or enhancing specific protein degradation. Interestingly, the present 
data confirm the complex mechanism of action of natural anti-oxidant compounds, which may 
account for the partial benefit observed in degenerative muscle conditions and that can be related to 
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their ability to dynamically interact with metabolism and endogenous anti-oxidant pathways 
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 Sarcomere organization and muscle contraction 
1 LIM domain-binding protein 3 Q9JKS4 Ldb3 Z-disc 77.6/.7.9 30.1/9.7 86 9/45 17% 0.0135 0.017 
2 LIM domain-binding protein 3 Q9JKS4 Ldb3 Z-disc 77.6/.7.9 29.6/9.7 89 11/34 15% 0.0267 0.028 
3 LIM domain-binding protein 3 Q9JKS4 Ldb3 Z-disc 77.6/.7.9 30.2/9.3 76 8/34 16% <0.0001 <0.0001 
4 LIM domain-binding protein 3 Q9JKS4 Ldb3 Z-disc 77.6/.7.9 82.4/7 62 7/19 15% <0.0001 0.0001 
5 LIM domain-binding protein 3 Q9JKS4 Ldb3 Z-disc 77.6/.7.9 82.3/6.9 65 9/26 17% 0017 0.0.0043 
6 Myozenin-1 Q9JK37 Myoz1 Cytoskeleton 31.4/8.6 31.7/7.9 121 15/77 67% 0.0003 0.0006 
7 Troponin I, fast skeletal muscle P13412 Tnnt2 Troponin complex 21.5/8.6 21.5/8.6 107 12/29 44% <0.0001 0.0003 
8 Troponin I, fast skeletal muscle P13412 Tnnt2 Troponin complex 21.5/8.6 21.6/8.4  100 12/55 47% 0.021 0.0242 
9 Troponin I, fast skeletal muscle P13412 Tnnt2 Troponin complex 21.5/8.6 21.5/8.5 100 17/58 52% <0.0001 0.0002 
10 Troponin T, fast skeletal muscle Q9QZ47 Tnnt3 Troponin complex 32.2/5.3 32.9/6.9 70 8/27 31% 0.0062 0.01 
11 Troponin T, fast skeletal muscle Q9QZ47 Tnnt3 Troponin complex 32.2/5.3 31.5/7.8 82 10/43 33% <0.0001 0.0001 
12 Troponin T, fast skeletal muscle Q9QZ47 Tnnt3 Troponin complex 32.2/5.3 31.9/9.2 74 8/27 26% 0.021 0.022 
13 
Myosin regulatory light chain 2, skeletal 
muscle isoform 
P97457 Mylpf Myosin complex 19/4.8 16.1/4.8 88 10/42 63% 0.0066 0.038 
14 
Myosin regulatory light chain 2, skeletal 
muscle isoform 
P97457 Mylpf Myosin complex 19/4.8 16.1/4.9 157 17/65 79% 0.0009 0.008 
15 
Myosin regulatory light chain 2, skeletal 
muscle isoform 
P97457 Mylpf Myosin complex 19/4.8 17/4.9 132 10/28 63% <0.0001 <0.0001 
16 
Myosin regulatory light chain 2, skeletal 
muscle isoform 
P97457 Mylpf Myosin complex 19/4.8 17.1/4.9 72 6/36 37% <0.0001 <0.0001 
17 Tropomyosin beta chain P58774 Tpm2 Cytoskeleton 32.9/4.7 36.1/4.9 74 11/38 29% <0.0001 0.0003 
18 Tropomyosin alpha-1 chain P58771 Tpm1 Cytoskeleton 32.7/4.7 34.3/4.9 109 12/30 32% <0.0001 0.0014 
19 
Myosin light chain 1/3, skeletal muscle 
isoform 
P05977 Myl1 Myosin complex 20.7/4.9 21.3/5.2 70 6/33 49% <0.0001 0.0008 
20 
Myosin light chain 1/3, skeletal muscle 
isoform 
P05977 Myl1 Myosin complex 20.7/4.9 24.6/5.1 71 8/32 38% <0.0001 <0.0001 
21 
Myosin light chain 1/3, skeletal muscle 
isoform 
P05977 Myl1 Myosin complex 20.7/4.9 21.1/5.1 65 5/22 37% <0.0001 0.028 
22 
Actin, alpha skeletal muscle and  Actin, 






Cytoskeleton 42.3/5.2 51.2/5.1 62 6/18 23% 0.006 0.035 
23 
Actin, alpha skeletal muscle and Actin, 







42.3/5.2 42.4/5.2 72 14/32 44% 0.0128 0.034 
29 
 








89.9/5.1 42.4/5.2 73 8/30 27% 
24 Actin, alpha cardiac muscle 1 P68033 Actc1 Cytoskeleton 42.3/5.2 42.6/5.2 55 5/17 18% 0.0003 0.0013 
25 Actin, alpha skeletal muscle P68134 Acta1 Cytoskeleton 42.3/5.2 42.6/5.1 134 14732 17% 0.0098 0.014 
26 Myotilin Q9JIF9 Myot 
Cytoskeleton/sarcole
mma 
55.7/9.2 59.5/9 64 7/21 16% 0.0072 0.003 
27 Myotilin Q9JIF9 Myot 
Cytoskeleton/sarcole
mma 
55.7/9.2 59.5/9.4 71 7/21 22% <0.0001 <0.0001 
 Metabolism 
(Glucose metabolism) 
28 Fructose-bisphosphate aldolase A P05064 Aldoa cytoplasm 39.7/8.3 38.3/7.4 117 13/47 52% 0.009 0.0135 
29 Fructose-bisphosphate aldolase A P05064 Aldoa cytoplasm 39.7/8.3 38.1/7.6 135 14/42 60% 0.012 0.0161 
30 Fructose-bisphosphate aldolase A P05064 Aldoa cytoplasm 39.7/8.3 30.4/7.1 60 6/25 16% <0.0001 <0.0001 
31 Fructose-bisphosphate aldolase A P05064 Aldoa cytoplasm 47.3/6.7 31.5/6.8 100 9/28 36% 0.007 0.0115 
32 Triosephosphate isomerase P17751 Tpi1 cytoplasm 32.7/5.5 24.9/6.4 117 11/37 45% <0.0001 <0.0001 
33 Triosephosphate isomerase P17751 Tpi1 cytoplasm 32.7/5.5 25/6.7 122 12/58 49% 0.006 0.0109 
34 Triosephosphate isomerase P17751 Tpi1 cytoplasm 32.7/5.5 25/6.7 91 8/26 34% 0.004 0.0079 
35 Triosephosphate isomerase P17751 Tpi1 cytoplasm 32.7/5.5 24.3/6.1    0.033 0.0035 
36 Triosephosphate isomerase P17751 Tpi1 cytoplasm 32.7/5.5 24.9/6.5 105 10/39 48% <0.0001 <0.0001 
37 Beta-enolase P21550 Eno3 cytoplasm 47.3/6.7 46.6/6.3 95 8/22 23% 0.035 0.034 
38 Beta-enolase P21550 Eno3 cytoplasm 47.3/6.7 46.7/6.3 109 12/41 37% 0.012 0.0159 
39 Beta-enolase P21550 Eno3 cytoplasm 47.3/6.7 46.5/6.6 121 15/39 39% 0.005 0.0019 







57.1/7.2 53.8/6.8 94 9/21 26% 0.0005 0.0017 
(TCA cycle and associate metabolic pathways) 
42 Fumarate hydratase, mitochondrial P97807 Fh mitochondrion 54.5/9.1 45.7/7.1 76 12/32 28% 0.001 0.003 
43 Fumarate hydratase, mitochondrial P97807 Fh mitochondrion 54.5/9.1 45.7/7.5 128 16/46 42% 0.002 0.005 










Q8CHT0 Aldh4a1 mitochondrion 62.2/8.4 63/6.8 70 8/30 22% 0.013 0.017 
47 Aconitate hydratase, mitochondrial Q99KI0 Aco2 mitochondrion 86.1/8.1 86.1/6.8 96 10/21 26% 0.002 0.005 
(Respiratory chain complex) 
48 
NADH dehydrogenase [ubiquinone] 
flavoprotein 2, mitochondrial Q9D6J6 Ndufv2 
mitochondrion 27.6/7 23.9/5.4 71 8/32 38% 0.002 0.026 
49 
NADH dehydrogenase [ubiquinone] 1 
beta subcomplex subunit 7 Q9CR61 Ndufb7 
mitochondrion 16.5/8.3 16.7/8.4 65 5/25 51% 0.009 0.014 
50 
Cytochrome b-c1 complex subunit 1, 
mitochondrial Q9CZ13 Uqcrc1 
mitochondrion 53.4/5.8 46.1/5.3 101 11/26 26% 0.009 0.013 
51 
ATP synthase subunit alpha, 
mitochondrial Q03265 Atp5a1 
mitochondrion 59.8/9.22 22.5/6.6 72 7/22 17% 0.032 0.033 
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(Fatty acid metabolic process) 
52 Fatty acid-binding protein, heart P11404 Fabp3 Cytoplasm 14.8/6.1 12.4/5.8 82 5%12 40% 0.0013 0.017 
53 Enoyl-CoA hydratase, mitochondrial Q8BH95 Echs1 Mitochondrion 31.8/8.8 26.5/8.0 104 9/25 36% 0.049 0.044 
54 
Succinyl-CoA:3-ketoacid coenzyme A 
transferase 1, mitochondrial Q9D0K2 Oxct1 
Mitochondrion 56.3/8.7 55.7/6.9 71 10/35% 29% 0.0002 0.0008 
Energy transfert 
55 Creatine kinase M-type P07310 Ckm cytoplasm 43.2/6.6 24.3/6.3 61 7/20 21% <0.0001 <0.0001 
56 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 28.8/6.6 69 8/25 22% 0.012 0.016 
57 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 29/6.6 66 10/39 27% <0.0001 <0.0001 
58 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 29.7/6.6 61 7/35 21% 0.0002 0.0008 
59 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 24.4/6.5 64 6/21 18% 0.002 0.005 
60 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 17.4/7.9 68 9/34 29% 0.002 0.005 
61 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 53.3/6.6 89 8/17 26% 0.018 0.023 
62 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 40.4/6.4 88 11/47 32% <0.0001 <0.0001 
63 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 40.4/6.4 119 13/25 45% 0.0003 0.0013 
64 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 40.7/6.5 133 13/34 46% 0.009 0.014 
65 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 40.2/6.6 177 19/61 51% 0.01 0.015 
66 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 41/7.8 58 7/22 24% 0.014 0.018 
67 Creatine kinase M-type P07310 Ckm Cytoplasm 43.2/6.6 59.6/6.6 116 8/18 29% 0.015 0.019 
68 Creatine kinase S-type, mitochondrial Q6P8J7 Ckmt2 Mitochondrion 47.9/8.6 41.4/6.1 255 24/57 54% 0.005 0.009 
69 
Nucleoside diphosphate kinase B Q01768 Nme2 
Nucleus and 
cytoplasm 
17.5/6.9 16.3/6.1 117 10/45 59% 0.0002 0.0009 
70 Adenylate kinase isoenzyme 1 Q9R0Y5 Ak1 Cytoplasm 21.6/5.7 21.5/5.3 58 5/20 36% <0.0001 <0.0001 
71 Adenylate kinase isoenzyme 1 Q9R0Y5 Ak1 Cytoplasm 21.6/5.7 22/5.5 104 11/40 55% 0.006 0.009 
Others metabolic process 
72 Alcohol dehydrogenase [NADP(+)] Q9JII6 Akr1a1 Cytosol 36.8/6.9 26.5/6.6 58 7/46 27% 0.0005 0.002 
73 Alcohol dehydrogenase [NADP(+)] Q9JII6 Akr1a1 Cytosol 36.8/6.9 57/6.1 62 6/20 18% 0.004 0.005 
74 Carbonic anhydrase 3 P16015 Ca3 Cytoplasm 29.6/6.9 26.6/7.6 66 5/20 28% 0.002 0.0009 
75 Carbonic anhydrase 3 P16015 Ca3 Cytoplasm 29.6/6.9 26.4/6.8 158 12/48 65% 0.0002 0.004 
76 Aldehyde dehydrogenase, mitochondrial P47738 Aldh2 Mitochondrion 57/7.5 51.6/6.27 72 8/26 19% 0.0004 0.001 
77 
Glyoxylate reductase/hydroxypyruvate 
reductase Q91Z53 Grhpr 
Cytoplasm 35.7/5.6 35.7/5.57 93 9/30 36% 0.0005 0.002 
78 Malate dehydrogenase, cytoplasmic P14152 Mdh1 Cytoplasm 36.6/6.1 34.2/6.5 68 8/35 25%   
Transport 
79 Hemoglobin subunit alpha P01942 Hba 
hemoglobin C 
complex 
15.1/7.9 12.3/8.2 90 9/73 66% 0.026 0.028 
80 Hemoglobin subunit beta-1 P01942 Hbb-b1 
hemoglobin C 
complex 
15.9/7.1 11.9/6.8 111 7/24 56% 0.0002 0.0009 
81 Serotransferrin- Q921I1 Tf Extracellular region 78.8/6.9 82.6/6.5 106 22% 14/35 <0.0001 <0.0001 
82 Serotransferrin Q921I1 Tf Extracellular region 78.8/6.9 82.7/6.6 79 20% 10/29 0.001 0.004 
83 Serotransferrin Q921I1 Tf Extracellular region 78.8/6.9 64.2/6.5 76 17% 9/23 0.011 0.015 
84 Serum albumin P07724 Alb Extracellular region 70.7/5.6 45.3/6.1 93 21% 11/31 0.031 0.032 




†Spot numbers match those reported in the representative 2DE images shown in Figure 1  
‡
 Accession number in Swiss-Prot/UniprotKB. 
§ 
Based on the calculation using Progenesis SameSpots 4.0 software 
¶ 
MASCOT MS score (Matrix Science, London, UK; http://www.matrixscience.com). MS matching score greater than 56 was required for a significant MS hit 
(p-value<0.05). 
║ 
Number of matched peptides correspond to peptide masses matching the top hit from Ms-Fit PMF, searched peptide are also reported. 
* 
Sequence coverage = (number of the identified residues/total number of amino acid residues in the protein sequence) x100%. 
₤ 
Anova test was performed by Progenesis SameSpots 4.0 software to determine if the relative change was statistically significant (p<0.05). 
┴ 
The False Discovery Rate (FDR) was calculated as q-value using Progenesis SameSpots 4.0 software in order to establish how many of the significant ANOVA 
p-values were false positives. Only the protein spots with an adjusted p-value (FDR)<0.05 were considered for the mass spectrometry analysis.  
¤
mix Mascot score 105 
 
86 Serum albumin P07724 Alb Extracellular region 70.7/5.6 34.8/5.6 132 33% 17/48 0.0093 0.0137 
87 
Voltage-dependent anion-selective 
channel protein 1 
Q60932 
Vdac1 
Mitochondrion 32.5/8.5 29.8/8.6 74 38% 6/21 0.0008 0.002 
88 
Voltage-dependent anion-selective 
channel protein 1 
Q60932 
Vdac1 
Mitochondrion 32.5/8.5 29.8/8.2 69 36% 6/22 0.011 0.015 
Others 
            
89 MICOS complex subunit Mic60 Q8CAQ8 Immt Mitochondrion 82.2/6.2 73/6.6 75 9/19 16% 0.006 0.01 
90 Calpain-7 Q9R1S8 Capn7 Nucleus 93.3/8.1 17.6/10.3 68 10/37 22% 0.025 0.0027 
91 26S protease regulatory subunit 8 P62196 Psmc5 Proteasome complex 45.8/7.1 44.6/6.8 78 9/21 26% 0.003 0.006 
92 Protein disulfide-isomerase A3 P27773 Pdia3 Endoplasmic reticulum 57.1/5.9 58.9/5.8 73 12/38 26% 0.004 0.007 
93 Peroxiredoxin-6 O08709 Prdx6 Cytoplasm 24.9/5.7 24.7/6.2 126 9/24 54% 0.019 0.023 
94 
Electron transfer flavoprotein subunit 
alpha, mitochondrial 
Q99LC5 Etfa Mitochondrion 35.5/8.6 34.2/6.6 86 717 30% 0.0007 0.002 
95 Heat shock protein beta-1 P14602 Hspb1 Proteasome complex 23/6.1 25.2/6.1 81 8/39 40% 0.013 0.017 
96 TBC1 domain family member 5 Q80XQ2 Tbc1d5 Endosome 92.3/6.3 35.1/6.6 57 8/24 14% 0.0005 0.0018 
97 Alpha-crystallin B chain P23927 Cryab Nucleus 20/6.8 19/6.8 139 11/49 61% 0.013 0.017 
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Fold change (mdx vs wt) was calculated dividing the average of %V of mdx by the average of %V 
of wt (V =volume=integration of the optical density over the spot area; %V = V single spot/V total 
spots included in the reference gel). 


















Anova p-value * 
Sarcomere structure and muscle contraction  
7 Troponin I, fast skeletal muscle -2.2 0.002 
8 Troponin I, fast skeletal muscle -1.6 0.047 
9 Troponin I, fast skeletal muscle -1.8 <0.0001 
16 Myosin regulatory light chain 2, skeletal muscle isoform -2.1 0.01 
17 Tropomyosin beta chain -2.3 0.0008 
18 Tropomyosin alpha-1 chain -1.8 0.01 
23 
Actin, alpha skeletal muscle and Actin, alpha cardiac muscle1 
Transitional endoplasmic reticulum ATPase 
-1.4 
0.045 
24 Actin, alpha cardiac muscle 1 -1.4 0.021 
Metabolism and energy transfer  
32 Triosephosphate isomerase -1.53 0.003 
33 Triosephosphate isomerase -1.4 0.031 
36 Triosephosphate isomerase -1.52 0.047 
39 Beta-enolase -1.4 0.011 
44 Malate dehydrogenase, mitochondrial -1.8 0.005 
49 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 1.8 0.005 
50 Cytochrome b-c1 complex subunit 1, mitochondrial -1.6 0.0036 
55 Creatine kinase M-type -2 0.02 
57 Creatine kinase M-type -2.5 0.0085 
59 Creatine kinase M-type 1.8 0.0006 
68 Creatine kinase M-type -1.5 0.029 
Others  
78 Malate dehydrogenase, cytoplasmic 1.4 0.039 
81 Serotransferrin 1.5 0.015 
93 Peroxiredoxin-6 -1.6 0.019 
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Table 3. Differentially abundant protein spots between mdx exe and mdx tibialis anterior muscles 
Spot No Protein name Fold change 





Anova p-value * 
Striated muscle contraction and sarcomere organization 
1
 
LIM domain-binding protein 3 (Ldb3) 1.52 0.038 
2 LIM domain-binding protein 3 (Ldb3) 1.82 0.045 
3 LIM domain-binding protein 3 (Ldb3) 1.89 <0.0001 
4 LIM domain-binding protein 3 (Ldb3) 1.28 0.018 
6 Myozenin-1  1.96 0.002 
7 Troponin I, fast skeletal muscle 1.88 0.034 
9 Troponin I, fast skeletal muscle 1.58 0.012 
11 Troponin T, fast skeletal muscle 2.04 0.002 
12 Troponin T, fast skeletal muscle 1.7 0.018 
14 









18 Tropomyosin alpha-1 chain -1.75 0.02 
20 Myosin light chain 1/3, skeletal muscle isoform -2.1 0.002 
22 
Actin, alpha skeletal muscle and  Actin, alpha 
cardiac muscle1 
1.87 0.047 
Glycolysis and gluconeogenesis 
28 Fructose-bisphosphate aldolase A 1.46 0.007 
29 Fructose-bisphosphate aldolase A 1.5 0.038 
30 Fructose-bisphosphate aldolase A 1.37 0.01 
31 Fructose-bisphosphate aldolase A 1.69 0.023 
32 Triosephosphate isomerase 1.56 0.002 
33 Triosephosphate isomerase 1.45 0.025 
34 Triosephosphate isomerase 2.1 0.002 
37 Beta-enolase 1.6 0.007 
38 Beta-enolase 1.61 0.005 
39 Beta-enolase 1.52 0.006 
40 Beta-enolase 1.47 0.02 
41 UTP--glucose-1-phosphate uridylyltransferase 1.56 <0.0001 
TCA and associated metabolic pathways 
42 Fumarate hydratase, mitochondrial 1.76 0.0009 
43 Fumarate hydratase, mitochondrial 1.56 0.0036 
44 Malate dehydrogenase, mitochondrial 1.73 0.019 





Respiratory chain complex 
49 
NADH dehydrogenase [ubiquinone] 1 beta 




51 ATP synthase subunit alpha, mitochondrial 1.7 0.03 
Fatty acid metabolic process 
52 Fatty acid-binding protein, heart -2.3 0.005 
53 Enoyl-CoA hydratase, mitochondrial 1.46 0.037 
54 




55 Creatine kinase M-type 2.4 0.0015 
56 Creatine kinase M-type 1.9 0.0072 
57 Creatine kinase M-type 1.5 0.0041 
58 Creatine kinase M-type 2.1 0.028 
59 Creatine kinase M-type -1.9 0.0006 
60 Creatine kinase M-type 2.4 0.003 
61 Creatine kinase M-type 1.7 0.025 
62 Creatine kinase M-type 1.5 0.0019 
63 Creatine kinase M-type 1.6 0.018 




















Fold change (mdx exe vs mdx) was calculated dividing the average of %V of mdx exe by the 
average of %V of mdx  (V =volume=integration of the optical density over the spot area; %V = V 
single spot/V total spots included in the reference gel). 
* Tukey's multiple comparisons test was calculated with GraphPad Prism. 
66 Creatine kinase M-type 2.33 0.032 
67 Creatine kinase M-type 1.3  0.013 
68 Creatine kinase S-type, mitochondrial 1.5 0.012 
69 Nucleoside diphosphate kinase B 5.5 0.003 
70 Adenylate kinase isoenzyme 1 -1.9 0.021 
Others 
72 Alcohol dehydrogenase [NADP(+)] 1.7 0.005 
74 Carbonic anhydrase 3 1.6 0.007 
75 Carbonic anhydrase 3 1.5 0.001 
77 Glyoxylate reductase/hydroxypyruvate reductase 1.9 0.002 
78 Malate dehydrogenase, cytoplasmic -1.3 0.005 
Transport 
82 Serotransferrin 1.5 0.028 
84 Serum albumin 1.87 0.047 
86 Serum albumin -1.3 0.0006 
87 




Voltage-dependent anion-selective channel protein 
1 
1.4 0.008 
89 MICOS complex subunit Mic60 1.3 0.032 
91 26S protease regulatory subunit 8 
1.5 0.021 
94 
Electron transfer flavoprotein subunit alpha, 
mitochondrial 
1.6 0.014 
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Table 4. Groups of proteins whose abundance was differently modified by the combination of 
exercise with apocynin or taurine treatment. 
  Comparison vs mdx
¤

















2 LIM domain-binding protein 3 1.52 ns (1.6) ns (1.6) ns (-1.2) ns (-1.1) 
18 Tropomyosin alpha-1 chain -1.75 ns (1.37) ns (1.16) ns (1.1) ns (1.74) 
22 Actin, alpha cardiac muscle 1 and 
Actin, alpha skeletal muscle 
 
1.87 




28 Fructose-bisphosphate aldolase A  1.46 ns (1.23) ns (1.14) ns (-1.14) ns (-1.28) 
29 Fructose-bisphosphate aldolase A 1.5 ns (1.26) ns (1.06) ns (-1.18) ns (-1.4) 
33 Triosephosphate isomerase 1.45 ns (1.53) ns (1.17) ns (-1.2) ns (-1.2) 
37 Beta-enolase  1.6 ns (1.24) ns (1.18) ns (-1.29) ns (-1.35) 
38 Beta-enolase 1.61 ns (1.27) ns (1.16) ns (-1.27) ns (-1.39) 
39 Beta-enolase 1.52 ns (1.25) ns (1.2) ns (-1.2) ns (-1.25) 
40 Beta-enolase 1.47 ns (1.17) ns (1.09) ns (-1.25) ns (-1.35) 
42 Fumarate hydratase, mitochondrial  1.76 ns (1.41) ns (1.36) ns (-1.24) ns (-1.17) 




1.38 ns (1.22) ns (1.31) ns (-1.27) ns (-1.2) 
49 
NADH dehydrogenase [ubiquinone] 1 
beta subcomplex subunit 
-1.35 ns (-1.18) ns (-1.26) ns (1.15) ns (1.07) 
51 
ATP synthase subunit alpha, 
mitochondrial 
I1.7 ns (1.51) ns (-1.1) ns (-1.16) ns (-1.95) 
52 Fatty acid-binding protein, heart -2.3 ns (-1.35) ns (-1.6) ns (1.7) ns (1.4) 
53 Enoyl-CoA hydratase, mitochondrial 1.46 ns (1.28) ns (1.31) ns (-1.21) ns (-1.19) 
56 Creatine kinase M-type  1.9 ns (1.39) ns (1.21) ns (-1.35) ns (-1.56) 
61 Creatine kinase M-type  1.7 ns (1.68) ns (1.41) ns (-1.02) ns (-1.24) 
62 Creatine kinase M-type  1.5 ns (1.67) ns (1.42) ns (-1.02) ns (-1.21) 
66 Creatine kinase M-type  2.33 ns (1.43) ns (1.2) ns (-1.62) ns (-1.93) 
68 Creatine kinase S-type, mitochondrial 1.5 ns (1.35) ns (1.1.18) ns (-1.13) ns (-1.29) 




1.9 ns (1.43) ns (1.54) ns (-1.32) ns (-1.23) 
78 Malate dehydrogenase, cytoplasmic -1.3 ns (-1.04) ns (-1.03) ns (1.24) ns (1.25) 
82 Serotransferrin 1.5 ns (1.27) ns (1.38) ns (-1.16) ns (-1.07) 
84 Serum albumin 1.87 ns (1.68) ns (1.31) ns (-1.06) ns (-1.35) 
88 
Voltage-dependent anion-selective 
channel protein 1 
1.4 ns (1.27) ns (1.26) ns (-1.11) ns (-1.12) 
89 MICOS complex subunit Mic60 1.3 ns (1.3) ns (1.31) ns (1.01) ns (1.02) 
91 26S protease regulatory subunit 8 1.5 ns (1.4) ns (1.42) ns (-1.1) ns (-1.09) 
94 
Electron transfer flavoprotein subunit 
alpha, mitochondrial 
1.6 ns (1.42) ns (1.2) ns (-1.13) ns (-1.34) 
Group II 
32 Triosephosphate isomerase 1.56 ns (-1.06) ns (-1.8) -1.65 -1.82 
34 Triosephosphate isomerase 2.1 ns (1.04) ns (1.15) -2.02 -1.81 
55 Creatine kinase M-type 2.4 1.97 ns (1.4) ns (-1.2) -1.71 
63 Creatine kinase M-type 1.6 ns (1.11) ns (-1.16) ns (-1.42) -1.83 
64 Creatine kinase M-type 1.5 ns (-1.02) ns (-1.04) -1.51 -1.55 
72 Alcohol dehydrogenase [NADP(+)] 1.7 ns (1.47) ns (1.19) ns (-1.17) -1.45 
Group III 
1 LIM domain-binding protein 3 1.52 ns (1.5) 1.5 ns (1.03) ns (1) 
4 LIM domain-binding protein 3 1.28 ns (1.3) 1.5 ns (1.01) ns (1.04) 
6 Myozenin-1 1.96 ns (1.53) 1.6 ns (1.07) ns (1.36) 
7 Troponin I, fast skeletal muscle 1.88 ns (1.5) 2.2 ns (-1.25) ns (1.16) 
9 Troponin I, fast skeletal muscle 1.58 ns (1.4) 1.6 ns (-1.1) ns (-1.01) 
10 Troponin T, fast skeletal muscle ns (1.38) ns (1.22) 1.8 ns (1) ns (1.33) 
12 Troponin T, fast skeletal muscle 1.7 ns (1.5) 1.9 ns (-1.1) ns (1.1) 
14 Myosin regulatory light chain 2, skeletal 
muscle isoform 
-1.83 -2 ns (-1.2) ns (-1.13) ns (1.24) 
19 Myosin light chain 1/3, skeletal muscle 
isoform 
ns (-1.6) -4.9 
 
ns (-2) ns (-2.01) ns (-1.3) 
20 Myosin light chain 1/3, skeletal muscle 
isoform 
-2.1 -2 ns (-1.5) ns (1.’04) ns (1.’35) 





 Significant fold changes are reported in bold; ns means not significant, the corresponding fold 
changes values are in italics between brackets and are reported in order to show the tendency. 
*
Fold change mdx exe vs mdx as reported in Table 3.  
ⱡ
Fold change mdx apo and mdx tau vs mdx. 
≠








31 Fructose-bisphosphate aldolase A 1.69 1.68 ns (1.51) ns (1.) ns (-1.1) 




1.56 1.37 ns (1.34) ns (-1.14)  ns (-1.14) 
44 Malate dehydrogenase, mitochondrial 1.73 1.7 ns (1.6) ns (-1.25) ns (-1.25) 
47 Aconitate hydratase, mitochondrial ns (1.14) 1.5 ns (1.16) ns (1.34) ns (1.02) 
48 
NADH dehydrogenase [ubiquinone] 
flavoprotein 2, mitochondrial 
ns (1.35) ns (-1.38) ns (-1.38) -1.9 -1.9 
54 
Succinyl-CoA:3-ketoacid coenzyme A 
transferase 1, mitochondrial 
1.5 ns (1.33) 1.4 ns (-1.13) ns (-1.08) 
57 Creatine kinase M-type 1.5 2.83 ns (2.2) ns (1.05) ns (1.22) 
58 Creatine kinase M-type 2.1 2.3 ns (1.8) ns (1.11) ns (-1.12) 
59 Creatine kinase M-type -1.9 -1.46 ns (-1.35) ns (1.29) ns (1.47) 
60 Creatine kinase M-type 2.4 2.3 ns (1.7) ns (-1.02) ns (-1.35) 
67 Creatine kinase M-type 1.3 ns (1.15) 1.4 ns (-1.14) ns (1.09) 
75 Carbonic anhydrase 3 1.5 1.35 ns (1.24) ns (-1.27) ns (-1.35) 
80 Hemoglobin subunit beta-1 ns (1.01) -1.3 -1.4 ns (-1.98) ns (-2.1) 
86 Serum albumin -1.3 -1.4 -1.63 ns (-1.07) ns (-1.26) 
87 
Voltage-dependent anion-selective 
channel protein 1 
1.4 1.41 ns (1.31) ns (1) ns (-1.07) 





Figure 1. Representative silver-stained 2DE gel image of tibialis anterior muscle from mdx mice. 
Proteins (70 µg) were separated by 2DE using IPG strips with a nonlinear pH gradient of 3–10 and 
9–16% linear gradient SDS-PAGE. Circles and numbers indicate statistically differentially 
abundant proteins between the five groups analysed. Numbers correspond to the spot numbers 
present in Table 1. 
Figure 2. PCA biplot. Red circle includes spots of gels from mdx (pink dots) and wt (light blue 
dots); blue circle includes spots of gels from mdx exe (blue dots) and mdx exe treated with 
apocynin (violet dots) and taurine (yellow dots).   
Figure 3. Over-representation enrichment analysis (ORA): enriched gene ontology categories (A) 
and pathway (B). Statistical enrichment was performed using WebGestalt web tool 
(http://webgestalt.org). R: ratio of enrichment; adjP: p value adjusted by the multiple test 
adjustment. Only categories with an adjP ≤0.05 are reported.  
Figure 4. Overview of 2DE results. Impact of exercise on proteins involved in sarcomere structure 
and muscle contraction. (*) indicates proteins whose Mr or/and pI were different than expected. 
Figure 5. Validation of proteomic results. Histograms and representative immunoblot images of 
Actin (panel A) and Aldoa, Tpi1 and Eno3 (panel B) from mdx and mdx exe mice. (n=5; mean ± 
S.D.; t-test unpaired). Normalization of immunoblot was performed on Coomassie stained gel as 
described in Materials and Methods. 
Figure 6. Immunoblot of electron chain complexes with total OXPHOS Rodent WB Antibody 
Cocktail. Histograms and representative immunoblot images from mdx and mdx exe mice. (n=5; 
mean ± S.D.; t-test unpaired). Normalization of immunoblot was performed on Coomassie stained 
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membrane as described in Materials and Methods.  Complex IV is visible only with prolonged 
exposition (not shown). 
Figure 7. Impact of exercise on proteins involved in glucose metabolism, TCA cycle and electron 
transport chain. Protein variation found by 2DE are represented inside the squares. Protein 
variations of each complex, arising from OXPHOS western blot analysis, are indicated in bold. 
Figure 8. Immunoblotting of exercise-related proteins. Histograms and representative immunoblot 
images of Sirt1 and PGC1-alpha in wt, mdx and mdx exe mice. (n=5; mean ± S.D.; one–way 
ANOVA). Normalization of immunoblot was performed on Coomassie stained gel as described in 
Materials and Methods 
Figure 9. Clustering representation of the three groups obtained considering treatments effect. 
Group I: spots whose abundance were modified by exercise, but that, with taurine and/or apocynin 
treatment, showed a reduction of this modification that became non-significant. Group II: spots that 
show a significant variation between mdx exe and mdx exe treated with compounds. Group III spots 
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